There is no universally agreed protocol for screening people who have been exposed to asbestos. Screening tests might diagnose<unk>  earlier than conventional methods thus improving the survival prospects for patients. The serum osteopontin level might be useful in screening asbestos-exposed people for<unk> . The level of soluble mesothelin-related protein is elevated in the serum of about 75% of patients at diagnosis and it has been suggested that it may be useful for screening. Doctors have begun testing the Mesomark assay, which measures levels of soluble mesothelin-related proteins (SMRPs) released by<unk>  cells.
Mesothelioma
Hemangioendothelioma
Epithelioid hemangioendothelioma
Pulmonary sclerosing pneumocytoma
Large-cell lung carcinoma
Giant-cell carcinoma of the lung
Sarcomatoid carcinoma of the lung
Sarcoma